-
PDF
- Split View
-
Views
-
Cite
Cite
A.P. Simopoulos, Evolutionary aspects of diet, essential fatty acids and cardiovascular disease, European Heart Journal Supplements, Volume 3, Issue suppl_D, June 2001, Pages D8–D21, https://doi.org/10.1016/S1520-765X(01)90113-0
- Share Icon Share
Abstract
Information from archaeological findings and studies from modern-day hunter-gatherers suggest that the Palaeolithic diet is the diet we evolved on and for which our genetic profile was programmed. During the Palaeolithic period the intake of omega-6 and omega-3 fatty acids was about equal. Epidemiological, experimental and clinical intervention studies have shown that omega-3 fatty acids affect the function of cells involved in atherothrombosis in numerous ways, including the modification of eicosanoid products in the cyclooxygenase and lipoxygenase pathways, the reduced synthesis of cytokines and platelet-derived growth factor by influencing gene expression and alterations in leukocyte and endothelial cell properties. In the secondary prevention of cardiovascular disease, omega-3 fatty acid supplementation leads to a decrease in cardiac deaths and total mortality. These effects are brought about without a decrease in plasma cholesterol levels, suggesting that the beneficial effects of omega-3 fatty acids in preventing sudden death are due to their antiarrhythmic properties. Because coronary heart disease is a multigenic and multifactorial disorder, it is essential that the patients are stratified by genetic susceptibility and disease entity, as well as sex, age and severity of disease. The composition of the diet must remain constant throughout the intervention period and also the ratios of saturated fat to unsaturated fat and the ratio of omega-6:omega-3 taken into consideration. Trans fatty acids should not comprise more than 2% of energy. The dose, duration and mechanisms involved in the prevention and management of cardiovascular disease following omega-3 fatty acid ingestion or supplementation need to be further investigated by double-blind controlled clinical trials.
References
GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.
Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study.
- anti-arrhythmia agents
- cytokine
- sudden death
- trans fatty acids
- cardiovascular diseases
- gene expression
- endothelial cells
- omega-3 fatty acids
- saturated fatty acids
- diet
- unsaturated dietary fats
- eicosanoids
- unsaturated fats
- essential fatty acids
- genetic predisposition to disease
- leukocytes
- lipoxygenase
- plasma
- platelet-derived growth factor
- prostaglandin-endoperoxide synthase
- cholesterol measurement test
- genetics
- heart
- mortality
- coronary heart disease
- atherothrombosis
- ingestion
- secondary prevention of cardiovascular disease
- prevention
- severity of illness